Dermatol. praxi. 2017;11(4):188-190 | DOI: 10.36290/der.2017.034

Infrared thermography in diagnosis of Raynaud’s phenomenon – 1st part

MUDr. Jan Šternberský1, Mgr. Jana Zapletalová, Dr.2
1 Klinika chorob kožních a pohlavních LF UP a FN Olomouc
2 Ústav lékařské biofyziky LF UP, Olomouc

Disorders of the acral blood circulation are relatively common disease, manifesting with cold hands. Raynaud’s phenomenon (RF)is typical representative of this type of disability. Two forms of RF are distinguished – primary , with no other associated diseaseand secondary, which is connected with other disease. It could be difficult to differentiate between RF and the other diseasesonly through history taking, because of episodic picture of RF. Objectivization of anamnestic data was made in this original studywith infrared thermography and cold water test. First part of this article is aimed on theoretical aspects of RF.

Keywords: cold hands, Raynaud’s phenomenon, infrared thermography, cold water test

Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šternberský J, Zapletalová J. Infrared thermography in diagnosis of Raynaud’s phenomenon – 1st part. Dermatol. praxi. 2017;11(4):188-190. doi: 10.36290/der.2017.034.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Maverakis E, Patel F, Kronenberg DG, et al. International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun. 2014; 48-49: 60-65. doi:10.1016/j.jaut.2014.01.020. Go to original source... Go to PubMed...
    2. Tomcik M. [Raynaud's phenomenon]. Cas Lek Cesk. 2016; 155(6): 310-318. Go to PubMed...
    3. Chikura B, Moore T, Manning J, Vail A, Herrick AL. Thumb involvement in Raynaud's phenomenon as an indicator of underlying connective tissue disease. J Rheumatol. 2010; 37(4): 783-786. doi:10.3899/jrheum.091117. Go to original source... Go to PubMed...
    4. Kuryliszyn-Moskal A, Kita J, Hryniewicz A. Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopy. Reumatologia. 2015; 53(2): 87-93. doi:10.5114/reum.2015.51508. Go to original source... Go to PubMed...
    5. Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015; 5(3): e006389. doi:10.1136/bmjopen-2014-006389. Go to original source... Go to PubMed...
    6. Gayraud M. Raynaud's phenomenon. Joint Bone Spine. 2007; 74(1): e1-8. doi:10.1016/j.jbspin.2006.07.002. Go to original source... Go to PubMed...
    7. Meier FMP, Frommer KW, Dinser R, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2012; 71(8): 1355. doi:10.1136/annrheumdis-2011-200742. Go to original source... Go to PubMed...
    8. Carter SA, Dean E, Kroeger EA. Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome. Circulation. 1988; 77(5): 988-996. Go to original source... Go to PubMed...
    9. Wigley FM, Herrick AL, Flavahan NA. Raynaud's Phenomenon. New York, USA: Springer; 2015: 61-62 Go to original source...
    10. Terenghi G, Bunker CB, Liu YF, et al. Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis. J Pathol. 1991; 164(3): 245-252. doi:10.1002/path.1711640310. Go to original source... Go to PubMed...
    11. Rodnan GP, Myerowitz RL, Justh GO. Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore). 1980; 59(6): 393-408. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.